Technology market

The Injectable Drug Delivery Technologies market size was valued at USD 564 Billion in 2021 and will reach USD 1,589 Billion by 2030, growing at a rate of 12.2% CAGR owing to increasing adoption of self-administration

Acumen Research and Consulting

Acumen Research and Consulting recently published a report titled “Injectable Drug Delivery Technology Market Size, Share, Analysis Report and Regional Forecast, 2022-2030”

LOS ANGELES, Aug. 18, 2022 (GLOBE NEWSWIRE) — The Global Injectable Drug Delivery Technology Market The size is valued at USD 564 billion in 2021 and is expected to reach a market size of USD 1,589 billion by 2030; with a CAGR of 12.2%.

As chronic disorders become more prominent and patient care shifts from the clinic to the home, drug owners will be required to offer new injectable products that combine clinical efficacy and distinct delivery experiences to meet the needs of this evolving market. The increase in the rapid approval of injectable products is a major factor driving the global market for injectable drug delivery technologies. For example, more than 40% of FDA-approved drugs are injectable, with intramuscular and subcutaneous drug delivery products accounting for a growing proportion of those approvals.

Some of the latest trends in the injectable drug delivery technology market in the industry are chronic disorders, development costs, home care, and the COVID-19 pandemic. Additionally, increase in innovations in the drug delivery industry is another factor driving the revenue of the injectable drug delivery technology market. Easy and efficient drug delivery through pre-filled syringes, pens, and auto-injectors will drive the market growth. Moreover, the increasing adoption of wearables and connected smart devices will create significant growth opportunities for the market during the forecast period 2022 to 2030.

Free Sample Report Request @

https://www.acumenresearchandconsulting.com/request-sample/859

Report cover:

Market

Injectable Drug Delivery Technology Market

Administration of injectable drugs

Technology market size 2021

$564 billion

Administration of injectable drugs

Technology Market Forecast 2030

$1.589 billion

Administration of injectable drugs

CAGR of the technology market between 2022 and 2030

12.2%

Administration of injectable drugs

Technology market analysis period

2018 – 2030

Administration of injectable drugs

Technology Market Base Year

2021

Administration of injectable drugs

Technology Market Forecast Data

2022 – 2030

Segments Covered

By formulation, by device type, by delivery method, by application and by region

Administration of injectable drugs

Regional scope of the technology market

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa

Profiled Key Companies

B. Braun Melsungen, Baxter International, Inc., Becton, Dickinson and Company, Bespak, Eli Lilly and Company, Gerresheimer, Pfizer Inc., Sandoz, Schott AG, Terumo, Teva Pharmaceuticals Industries Ltd. and Ypsomed AG.

Report cover

Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulatory Analysis

Impact of COVID-19 on the Global Injectable Drug Delivery Technology Market Value

The demand for injectable drug delivery products has skyrocketed during the COVID-19 pandemic. Many overstretched healthcare systems are now increasingly focused on remote monitoring of as many conditions as possible, while patients themselves are keen to stay home as much as possible due to the coronavirus outbreak. COVID. This has increased the pressure on biopharmaceutical companies to not only launch new treatments faster and more efficiently than ever before, but also to incorporate attributes that make self-administered treatments as convenient, safe and effective as possible. Although the COVID-19 pandemic has disrupted the supply chain of some injectable drug delivery systems, it has created huge opportunities in the R&D sector. Additionally, government support for the development of these technologies is expected to drive the global injectable drugs market over the forecasted period of 2022 to 2030.

Rising adoption of self-administration and rising trend of home care is driving the growth of the injectable drug delivery technology market

With the introduction of new technologies, increased patient empowerment, and improved drug delivery mechanisms, patients are beginning to seek safer and more convenient delivery methods, favoring self-administered formulations over formulations administered in a hospital setting. The COVID-19 pandemic has changed people’s perspectives and expectations of birthing settings, contributing to an increase in self-administration of medication. As this becomes the norm, many manufacturers are moving to make the patient experience a vital part of drug delivery design. When it comes to home drug delivery, the most basic delivery system consists of vials and prefilled syringes. However, this method has several drawbacks and prefilled syringes have become the standard of care. Unfortunately, problems with prefilled syringes persist.

View the report’s detailed table of contents @

https://www.acumenresearchandconsulting.com/table-of-content/injectable-drug-delivery-technology-market

Infection Associated with Needlestick Injuries Hamper Injectable Drug Delivery Technology Market Share

As drug administration by injection has moved into the home, the importance of needlestick safety has moved beyond the formal health care setting. Each year, 320,000 needle stick incidents occur in hospital and non-hospital settings in the United States. Improving adherence in non-hospital or home settings is particularly important as self-administration in home or non-hospital settings continues to increase in Europe and the United States. Several governments and regulatory bodies such as Needlestick Safety and Prevention Act and Occupational Safety and Health Administration (OSHA) have imposed strict guidelines for the use of self-injection. As a result, this factor limits the growth of the market.

Injectable Drug Delivery Technology Market Segmentation

The global market is divided into five segments: formulation, device type, delivery method, application and region.

Based on formulation, the market is divided into nanoparticles, liposomes, microspheres and others. By device type, segmentation is given into needle-free injectors, reusable needles, pre-filled syringes, auto-injectors, pen needles, disposable syringes and others. Intraperitoneal, intravenous, intramuscular, subcutaneous and others are the categorization of delivery mode segment. Further, based on applications, the market is bifurcated into oncology, orphan diseases, autoimmune diseases, and others.

Injectable Drug Delivery Technology Market Regional Outlook

The global injectable drug delivery technology market is divided into five regions: North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. North America will dominate the global market with maximum shares till 2030. Rising elderly population, increasing prevalence of chronic disorders and rising trend of home medication administration are supporting the North American market injectable drug delivery technologies. However, Asia-Pacific is expected to witness the fastest growth in the coming years due to growing awareness of drug delivery technologies and increasing vigilance related to safety and comfort. In addition, the shift of patients from conventional drug delivery systems to off-the-shelf injectables is also fueling the Asia Pacific injectable drug delivery technology market.

Buy this premium research report –

https://www.acumenresearchandconsulting.com/buy-now/0/859

Injectable Drug Delivery Technology Market Players

Some of the major injectable drug delivery technology companies covered in the industry are B. Braun Melsungen, Baxter International, Inc., Becton, Dickinson and Company, Bespak, Eli Lilly and Company, Gerresheimer, Pfizer Inc., Sandoz, Schott AG, Terumo, Teva Pharmaceuticals Industries Ltd. and Ypsomed AG.

Browse more research topics on Health care Sector:

The Global Erythropoietin Drugs Market should grow to a CAGR of around 5.8% from 2020 to 2027 and is expected to reach market value of approximately $14.2 billion by 2027.

The Global Anti-allergy Drugs Market should grow to a CAGR of around 6.8% from 2020 to 2027 and is expected to reach market value of approximately $39.5 billion by 2027.

The Global Immune Health Supplements Market counted $15,567.8 million in 2020 with a considerable number 7.5% CAGR during the analysis period from 2021 to 2028.

About Acumen Research and Consulting:

Acumen Research and Consulting is a global provider of information and consulting services in the information technology, investment, telecommunications, manufacturing and consumer technology markets. ARC helps investment communities, IT professionals, and business executives make fact-based decisions about technology purchases and develop business growth strategies to compete in the marketplace . With a team of over 100 analysts and a collective industry experience of over 200 years, Acumen Research and Consulting ensures to provide a combination of industry knowledge with global and national level expertise.

For the latest update, follow us on Twitter and, LinkedIn

Contact us:

Mr. Richard Johnson

Acumen Research and Consulting

USA: +13474743864

India: +918983225533

E-mail: [email protected]